Statistics
Publications
80
Citations
14.1K
H-Index
44
Active since
2002
Maximilian von Eynatten is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and pharmacotherapy.
Publications per year
2002–2023
80
80
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.6K citations · Full text
1–5 of 80